![]()
|
![]()
|
||||||||||||||||||
|
Chief Complaint
Progressive shortness of breath. History of Present Illness
The patient is a 39 year old African American female who was diagnosed with pulmonary
sarcoidosis 1.5 years prior to JHH admission after presenting with shortness of breath.
At
that time, radiologic studies showed parenchymal infiltrates and mediastinal adenopathy.
The
pathology of a lung wedge resection 1 year prior to admission was reviewed at JHH and
showed
granulomatous inflammation. Her FVC was 70% predicted and DLCO 57% predicted. She began
oral corticosteroid therapy without significant symptomatic improvement. Six months prior
to
admission, the patient had continued dypsnea and a transthoracic ultrasound and right
heart
catheterization showed the presence of pulmonary hypertension with mean PA pressure 50-55
mmHg. She was started on an oral endothelin antagonist (Bosentan) which was discontinued
after 5 months due no improvement in symptoms. The patient was admitted two separate
times
to an outside hospital 3 and 1 month prior to JHH admission for suspected pneumonia. At
that
time, during a 6 minute walk test, her SaO2 fell from 94% to 83% while inspiring 4 L/min
nasal oxygen.
Past Medical History
Sarcoidosis Family History The patients mother is alive and has coronary artery disease and hypertension. Her father died at an early age of a myocardial infarction that was thought to be drug related. There is also a history of breast and gastric cancer in her family. Social History The patient lives at home with her husband, daughter, and son. She is a registered nurse. Prior to her decline in health, she had worked with mentally handicapped individuals. The patient has a remote smoking history of one year. She occasionally drinks alcohol. Medications (prior to presentation to outside ED)
Bactrim 1 single strength/day Allergies No known drug allergies. Review of Systems The patient reports pink frothy sputum production, wheezing, and a 3 pillow orthopnea. The patient does not report chest pain. Physical Exam on Admission (upon transfer)
Laboratory Values on Transfer
Clinical Course The patient was admitted and treated for a suspected sarcoid flare with increasing doses of prednisone. Piperacillin/tazobactam and azithromycin were given for possible pneumonia. Trimethoprim/sulfamethoxazole was also given for possible pneumocystis pneumonia. Sildenafil was started for the management of pulmonary hypertension. The patient was also given lasix, nebulizer treatments, and was continued on oxygen 4L NC. A chest CT 1 day after admission (Images 1-3) showed a patchy ground glass infiltrate involving the left lung, particularly in the upper lobe. The right lung was also involved, but to a lesser degree. Adenopathy was present in hilar, mediastinal, paratracheal, and supraclavicular nodes. The patient also continued to report shortness of breath. A portable chest x-ray (Image 4) showed a diffuse infiltrate of the left lung and no definitive infiltrate in the right lung. At around 11 am, the patient had rapid onset of weakness and decreased mental status. The patient lost consciousness and was found to be in PEA arrest. Resuscitation was not successful. Images of Radiologic Studies
Images 1-3: Chest CT shows bilateral ground glass opacities,
with patchy consolidative soft tissue density in left lung. Diffuse
lymphadenopathy in mediastinum and neck. Questions What is the differential diagnosis of granulomatous inflammation in the lung? What is the most likely cause of her pulmonary hypertension? What are the possible causes of the patients worsening shortness of breath over months and eventual demise?
|
|||||||||||||||||||
|
|||||||||||||||||||